1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe STRIVE™ Awards Program is sponsored by PTC Therapeutics. The STRIVE Awards program recognizes and supports nonprofit organizations committed to serving rare disease communities, with a focus on Duchenne Muscular Dystrophy (DMD).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The STRIVE™ Awards Program by PTC Therapeutics STRIVE™ Awards Program The PTC Therapeutics grant awards program Strategies to Realize Innovation, Vision, and Empowerment (STRIVE) recognizes and supports nonprofit organizations committed to serving rare disease communities. By recognizing the vital role patient advocacy groups play, we can give voice to those affected by these rare diseases.
The STRIVE Awards program was first launched in 2015 and occurs annually.
It was designed to support programs that address unmet needs for the Duchenne community, to: Improve diagnosis and treatment of patients Improve quality of life for those living with Duchenne and their families Educate the public and healthcare professionals and raise Duchenne awareness Identify and foster the next generation of Duchenne patient advocates Award categories for the 2023 STRIVE Awards were: Innovative: programs that help address the unmet needs of the rare disease community Transition to Adulthood: programs that support young people with Duchenne in their ‘transition to adulthood’ The STRIVE Awards application window is expected to open in January.
Funding will be granted to initiatives that positively impact the broader Duchenne community, including patients, their families and healthcare professionals.
The Awards are recognized for one year Submissions will be judged by an independent committee of experts, who have pertinent experience in rare diseases, patient advocacy, and funding initiatives Discover all the amazing advocacy efforts that have been sponsored by STRIVE grants for Duchenne patient advocacy If you would like additional information about the STRIVE grant program
According to the current listing, eligibility includes: Nonprofit organizations committed to serving rare disease communities, particularly those addressing unmet needs for the Duchenne community, or working in other rare disease areas of interest to PTC Therapeutics (Phenyl…. Confirm the full requirements in the official notice before applying.
The STRIVE™ Awards Program is funded by PTC Therapeutics. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.